RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 226,609 Value ($000) $927 Avg Close $4.95 Range $3.81 - $7.18

Q3 2025

Shares 78,259 Value ($000) $382 Avg Close $5.25 Range $4.45 - $7.15

Q2 2025

Shares 86,312 Value ($000) $437 Avg Close $4.91 Range $3.79 - $6.11

Q1 2025

Shares 333,612 Value ($000) $1,765 Avg Close $7.29 Range $5.19 - $12.36

Q1 2024

Shares 391,518 Value ($000) $3,903 Avg Close $11.14 Range $8.68 - $15.74

Q1 2023

Shares 514,137 Value ($000) $3,429 Avg Close $7.93 Range $6.40 - $9.73

Q2 2022

Shares 106,786 Value ($000) $869 Avg Close $6.69 Range $4.92 - $9.40

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	226,609	$927	$4.95	$3.81 - $7.18
Q3 2025	78,259	$382	$5.25	$4.45 - $7.15
Q2 2025	86,312	$437	$4.91	$3.79 - $6.11
Q1 2025	333,612	$1,765	$7.29	$5.19 - $12.36
Q1 2024	391,518	$3,903	$11.14	$8.68 - $15.74
Q1 2023	514,137	$3,429	$7.93	$6.40 - $9.73
Q2 2022	106,786	$869	$6.69	$4.92 - $9.40